Weston Medical trial results boost prospect of sale
Initial unaudited results of a clinical trial of Weston Medical's Intraject, a single dose, pre-filled disposable needle-free liquid injection system, seem positive, according to KPMG, boosting hopes of a successful sale of the company's assets.
Initial unaudited results of a clinical trial of Weston Medical's Intraject, a single dose, pre-filled disposable needle-free liquid injection system, seem positive, according to KPMG, boosting hopes of a successful sale of the company's assets.
Technical issues previously hindering the product appear to have been resolved.
KPMG was appointed administrators to the troubled drug delivery company. 'This is good news,' said Jane Moriarty, partner in KPMG Corporate Recovery. 'These initial results indicate that there may be a variety of potentially commercially viable applications for Intraject. We have already had several expressions of interest from potential purchasers.'
The final results of the trial are expected in the next few weeks.